Validation of mood measures for people with multiple sclerosis
- PMID: 25061435
- PMCID: PMC4106390
- DOI: 10.7224/1537-2073.2013-013
Validation of mood measures for people with multiple sclerosis
Abstract
Background: Valid assessments are needed in order to identify anxiety and depression in people with multiple sclerosis (MS). The objective of this study was to assess the validity of questionnaire measures of mood in people with MS.
Methods: People with MS were recruited from a clinic database and asked to complete and return a questionnaire containing the Beck Anxiety Inventory (BAI), Beck Depression Inventory-II (BDI-II), and Hospital Anxiety and Depression Scale (HADS). Those who returned the questionnaire were invited to complete a structured clinical interview, which was blind to the results of the questionnaire.
Results: The BDI-II and HADS were both found to be valid measures to detect depression and anxiety in people with MS. An optimum cutoff score of 23 for the BDI-II yielded high sensitivity (85%) and high specificity (76%). An optimum cutoff score of 11 for the HADS demonstrated high sensitivity and specificity for both the Anxiety subscale (sensitivity 90%, specificity 92%) and the Depression subscale (sensitivity 77%, specificity 81%). The BAI had high sensitivity (80%) but poor specificity (46%) for detecting anxiety.
Conclusion: The BDI-II and HADS can be used to identify mood disorders in people with MS.
Figures


Similar articles
-
Discriminant validity of the Hospital Anxiety and Depression Scale, Beck Depression Inventory (II) and Beck Anxiety Inventory to confirmed clinical diagnosis of depression and anxiety in patients with chronic obstructive pulmonary disease.Chron Respir Dis. 2016 Aug;13(3):220-8. doi: 10.1177/1479972316634604. Epub 2016 Mar 3. Chron Respir Dis. 2016. PMID: 26944070 Free PMC article.
-
Screening for depression in people with epilepsy: comparative study among neurological disorders depression inventory for epilepsy (NDDI-E), hospital anxiety and depression scale depression subscale (HADS-D), and Beck depression inventory (BDI).Epilepsy Behav. 2014 May;34:50-4. doi: 10.1016/j.yebeh.2014.03.003. Epub 2014 Mar 28. Epilepsy Behav. 2014. PMID: 24681386
-
Screening for anxiety and depression in dialysis patients: comparison of the Hospital Anxiety and Depression Scale and the Beck Depression Inventory.J Psychosom Res. 2012 Aug;73(2):139-44. doi: 10.1016/j.jpsychores.2012.04.015. Epub 2012 Jun 11. J Psychosom Res. 2012. PMID: 22789418
-
The prevalence of depression and anxiety among Iranian people with multiple sclerosis: A systematic review and meta-analysis.Mult Scler Relat Disord. 2023 Oct;78:104922. doi: 10.1016/j.msard.2023.104922. Epub 2023 Aug 5. Mult Scler Relat Disord. 2023. PMID: 37597350 Review.
-
Accuracy of the Hospital Anxiety and Depression Scale Depression subscale (HADS-D) to screen for major depression: systematic review and individual participant data meta-analysis.BMJ. 2021 May 10;373:n972. doi: 10.1136/bmj.n972. BMJ. 2021. PMID: 33972268 Free PMC article.
Cited by
-
Effects of a Remote Multimodal Intervention Involving Diet, Walking Program, and Breathing Exercise on Quality of Life Among Newly Diagnosed People with Multiple Sclerosis: A Quasi-Experimental Non-Inferiority Pilot Study.Degener Neurol Neuromuscul Dis. 2024 Jan 9;14:1-14. doi: 10.2147/DNND.S441738. eCollection 2024. Degener Neurol Neuromuscul Dis. 2024. PMID: 38222092 Free PMC article. Clinical Trial.
-
Lower corticospinal excitability and greater fatigue among people with multiple sclerosis experiencing pain.Mult Scler J Exp Transl Clin. 2023 Jan 5;9(1):20552173221143398. doi: 10.1177/20552173221143398. eCollection 2023 Jan-Mar. Mult Scler J Exp Transl Clin. 2023. PMID: 36636581 Free PMC article.
-
Internet-delivered cognitive behavioural therapy programme to reduce depressive symptoms in patients with multiple sclerosis: a multicentre, randomised, controlled, phase 3 trial.Lancet Digit Health. 2023 Oct;5(10):e668-e678. doi: 10.1016/S2589-7500(23)00109-7. Lancet Digit Health. 2023. PMID: 37775187 Free PMC article. Clinical Trial.
-
Hospital Anxiety and Depression Scale Anxiety subscale (HADS-A) for detecting anxiety disorders in adults.Cochrane Database Syst Rev. 2025 Jul 2;7(7):CD015456. doi: 10.1002/14651858.CD015456. Cochrane Database Syst Rev. 2025. PMID: 40600405 Review.
-
Cognitive fatigue in multiple sclerosis is associated with alterations in the functional connectivity of monoamine circuits.Brain Commun. 2021 Mar 5;3(2):fcab023. doi: 10.1093/braincomms/fcab023. eCollection 2021. Brain Commun. 2021. PMID: 33842886 Free PMC article.
References
-
- Feinstein A. Depression and multiple sclerosis. Mult Scler. 2011;17:1276–1281. - PubMed
-
- Lobentanz I, Asenbaum S, Vass K. Factors influencing quality of life in multiple sclerosis patients: disability, depressive mood, fatigue and sleep quality. Acta Neurol Scand. 2004;110:6–13. et al. - PubMed
-
- Tsivgoulis G, Triantafyllou N, Papageorgiou C. Associations of the Expanded Disability Status Scale with anxiety and depression in multiple sclerosis outpatients. Acta Neurol Scand. 2007;115:67–72. et al. - PubMed
-
- Jose Sa M. Psychological aspects of multiple sclerosis. Clin Neurol Neurosurg. 2008;110:868–877. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources